![]() |
|||
| Policies | Emergency Guide | Report Unsafe Conditions | UD Home | EHS Home | ||
Pharmaceuticals and/or Active Ingredients that are Hazardous WastesPharmaceuticals used for
treatment in a hospital or clinic setting, as well as teaching and
research must be disposed of and managed properly. Some
specific drugs or the active ingredients are hazardous wastes and could
harm human health or the environment if disposed of improperly. Other
antiseptics, pain killers, antibiotics, etc. still require proper
management and must not be disposed into sanity sewer system or normal
trash. Always check the Material Safety Data Sheet (MSDS) for indicators
that the pharmaceuticals are hazardous and require special management
through the chemical waste or biological waste programs. Some indicators
are the words carcinogen or potential carcinogen, toxic, flammable,
corrosive or hazardous. The National Fire Protection Association Fire
Rating Diamond also will indicate if the material is hazardous. Below is
a list of common pharmaceuticals, active ingredients or drug classes that
are hazardous or chemical wastes. This list in not inclusive and you
should always check the active ingredients, MSDS and/or contact DEHS for
disposal guidance.
Also go to the U.S. Drug Enforcement Agency's web site for a list of drugs and drug active ingredients that they regulate and which require special management. Contact DEHS if you use any of these compounds in your research or for treatment of patients. Working with hazardous drugs and antineoplastic compounds can be
hazardous to the researcher, lab technician, doctor or nurse. Please
review the NIOSH publication, Preventing
Occupational Exposures
to Antineoplastic and Other Hazardous Drugs in Health Care Settings
(PDF document), and
contact Jane Frank at
x8288 for information on the University's procedures for working with
Hazardous Drugs or visit EHS Standard Operating
Procedures/Job Hazard Analysis.
Questions
regarding chemical waste issues may be addressed to Jane Frank or call 831-2103.
|
|||